Severe speech impairment is a distinguishing feature of FOXP1-related disorder.

Saved in:
Bibliographic Details
Title: Severe speech impairment is a distinguishing feature of FOXP1-related disorder.
Authors: Braden RO; Murdoch Children's Research Institute, Parkville, VIC, Australia.; Department of Audiology and Speech Pathology and Department of Paediatrics, University of Melbourne, Parkville, VIC, Australia., Amor DJ; Murdoch Children's Research Institute, Parkville, VIC, Australia.; Department of Audiology and Speech Pathology and Department of Paediatrics, University of Melbourne, Parkville, VIC, Australia.; The Royal Children's Hospital, Parkville, VIC, Australia.; Victorian Clinical Genetics Service, Parkville, VIC, Australia., Fisher SE; Language and Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, the Netherlands.; Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, the Netherlands., Mei C; Murdoch Children's Research Institute, Parkville, VIC, Australia.; Orygen and Centre for Youth Mental Health, University of Melbourne, Parkville, VIC, Australia., Myers CT; Department of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, WA, USA., Mefford H; Department of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, WA, USA., Gill D; TY Nelson Department of Neurology, The Children's Hospital at Westmead, Sydney, NSW, Australia., Srivastava S; Department of Neurology, Boston Children's Hospital, Boston, MA, USA., Swanson LC; Department of Neurology, Boston Children's Hospital, Boston, MA, USA., Goel H; Hunter Genetics, John Hunter Hospital, New Lambton Heights, NSW, Australia., Scheffer IE; Murdoch Children's Research Institute, Parkville, VIC, Australia.; Department of Audiology and Speech Pathology and Department of Paediatrics, University of Melbourne, Parkville, VIC, Australia.; The Royal Children's Hospital, Parkville, VIC, Australia.; Austin Health, Heidelberg, Melbourne, VIC, Australia.; Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia., Morgan AT; Murdoch Children's Research Institute, Parkville, VIC, Australia.; Department of Audiology and Speech Pathology and Department of Paediatrics, University of Melbourne, Parkville, VIC, Australia.; The Royal Children's Hospital, Parkville, VIC, Australia.; Victorian Clinical Genetics Service, Parkville, VIC, Australia.
Source: Developmental medicine and child neurology [Dev Med Child Neurol] 2021 Dec; Vol. 63 (12), pp. 1417-1426. Date of Electronic Publication: 2021 Jun 09.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Blackwell Country of Publication: England NLM ID: 0006761 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1469-8749 (Electronic) Linking ISSN: 00121622 NLM ISO Abbreviation: Dev Med Child Neurol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1469-8749
DOI:10.1111/dmcn.14955